The Space called “Digital Therapeutics”

This piece defined “digital therapeutics” this way: “Today’s modern mobile health devices feature software applications (apps) designed to remotely treat chronic conditions by helping modify patient behavior, as well as monitoring drug intake and physical condition biomarkers. These devices are dubbed “Digital Therapeutics,” and they present opportunities for anatomic pathology groups and clinical laboratories.” Those opportunities are for the labs to do baseline blood tests. At present that market is $1.7 billion; by 2025, it may grow to $9 billion. MORE